Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating prostate cancer with an anti-PSMA/CD3 antibody

Methods of treating prostate cancer with an anti-PSMA/CD3 antibody

US Patent 11591395 · Granted Feb 28, 2023

Estimated economic value: $178,787,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating cancers with antagonistic anti-PD-1 antibodies2025
Anti-CD28 x anti-PSMA antibodies2025
Anti-CD28 x anti-PSMA antibodies2025
Radiolabeling of polypeptides2025
Proteins comprising kallikrein related peptidase 2 antigen binding domains and t2024
Anti-human kallikrein-2 (hK2) chimeric antigen receptor (CAR) and methods of use2024
Anti-PSMA antibodies and uses thereof2024
PSMA binding agents and uses thereof2023
Methods of treating cancer using PRMT5 inhibitors2023